Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.610
-0.050 (-3.01%)
Oct 3, 2025, 4:00 PM EDT - Market closed

Zentalis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
1162161,0721,1493,8082,109
Upgrade
Market Cap Growth
-60.74%-79.86%-6.72%-69.82%80.54%-
Upgrade
Enterprise Value
-146-1326017753,4431,769
Upgrade
Last Close Price
1.613.0315.1520.1484.0651.94
Upgrade
PS Ratio
4.293.20----
Upgrade
PB Ratio
0.420.642.452.6510.456.33
Upgrade
P/TBV Ratio
0.420.642.472.6710.577.13
Upgrade
Debt / Equity Ratio
0.150.130.110.110.130.01
Upgrade
Asset Turnover
0.060.14----
Upgrade
Quick Ratio
7.787.136.967.727.7411.85
Upgrade
Current Ratio
7.997.327.167.987.9812.07
Upgrade
Return on Equity (ROE)
-49.55%-42.83%-67.09%-59.39%-47.60%-59.01%
Upgrade
Return on Assets (ROA)
-25.41%-23.86%-28.53%-28.59%-31.67%-32.77%
Upgrade
Return on Capital (ROIC)
-28.86%-27.15%-32.27%-31.86%-34.82%-36.70%
Upgrade
Earnings Yield
-140.16%-76.80%-27.25%-20.60%-4.17%-5.59%
Upgrade
FCF Yield
-130.10%-79.23%-19.44%-14.47%-4.21%-4.15%
Upgrade
Buyback Yield / Dilution
-0.90%-8.67%-23.75%-23.82%-51.84%-402.29%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q